A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
Clinical trial NCT03107026 · COMPLETED
Trial details
- NCT number
- NCT03107026
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2018-05-16
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.